NANORAY-312: A Phase III Pivotal Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-Based Chemotherapy-Ineligible Elderly Patients with Locally Advanced HNSCC

Autor: S.S. Yom, Z. Takacsi-Nagy, X. Liem, S. Salas, A. Debard, L. Finzi, O.I. Vivar, L.A. Farber, M. Gogishvili, G. Kristesashvili, T. Makharadze, C. Hoffmann, C. Le Tourneau
Rok vydání: 2022
Předmět:
Zdroj: International Journal of Radiation Oncology*Biology*Physics. 114:e313
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2022.07.1372
Databáze: OpenAIRE